Table 4.
Variable | B | β | t | p | B: CI 95% | ΔR2 |
---|---|---|---|---|---|---|
Model 1 | ||||||
Constant | 2.44 | 1.46 | .163 | [− 1.09; 5.96] | ||
EEG high beta T1 | 0.12 | .07 | 0.28 | .785 | [− 0.78; 1.01] | .01 |
R2 adj = − .06; F(1, 16) = 0.08; p = .785 | ||||||
Model 2 | ||||||
Constant | 9.77 | 3.61 | .003 | [3.99; 15.54] | ||
EEG high beta T1 | 0.04 | .02 | 0.10 | .920 | [− 0.69; 0.76] | .01 |
Somatic self-efficacy T1 | − 2.07 | − .63 | − 3.11 | .007 | [− 3.48; − 0.65] | .39 |
R2 adj = .32; F(2, 15) = 4.91; F change = 9.69; p = .023 |
Y = Binge eating episodes post treatment, n = 18, T1 = post-treatment